NuVasive (NUVA) Tops Q2 EPS by 4c; Guides Abovce
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Brean Capital Raises Price Target on NuVasive (NUVA) to $70 Following Solid 2Q
July 27, 2016 11:04 AM EDTBrean Capital reiterated a Buy rating on NuVasive (NASDAQ: NUVA), and raised the price target to $70.00 (from $60.00), following the company's 2Q earnings report.
Analyst Jason Wittes commented, "NUVA reported a 16.4% (16.1% cc) revenue increase to $236.2 millionabove consensus and our $233.0 million estimate and was strong... More
NuVasive (NUVA) PT Raised to $72 at Jefferies
July 27, 2016 8:48 AM EDTJefferies analyst Raj Denhoy reiterated a Buy rating and lifted his price target on NuVasive (NASDAQ: NUVA) to $72.00 (from $63.00) following results.
Denhoy commented, "NuVasive put up a $2mn/$0.01 rev./EPS beat and raised guidance for the year. The top-line (+8.6% ex-FX, ex-NSO) was... More
